Quality is our legacy     
.
Site Language
.
.

.
 Search 
   Home
 
SEDICO Company
About SEDICO
News and Reports
Worldwide Presence
Careers at SEDICO
 
SEDICO products
Products List
Strategic Brands
Search for a product
 
Social Contribution
Diabetes Center
R&D
Caring for community
Access for medicines
 
Contact SEDICO
Contact Us
Distributors Log in
Partners Log in
Vendors Log in
Physicians Log in
Patients Log in
 
SEDICO Newsletter
Subscribe to SEDICO News

   Enter Your E-mail
 

Physician
Patient

Insulin H BIO R    

(Recombinant human insulin)
40 or 100 IU / ml suspension.10 ml

Human Insulin Production in Egypt, Insulin R 100 IU

Human Insulin Production in Egypt


Composition:
Each 1 ml contains recombinant human insulin 40-100 IU, Metacresol, glycerol, water for the injection.


Indications:
‎Diabetes mellitus type I: (insulin dependant) in children and adults.
‎Diabetes mellitus type II :( non insulin dependant) at the stage of resistance of per-oral hypoglycemic drugs, particular resistance to drugs (combined therapy), undercurrent diseases, surgical operations (mono or combined therapy), & diabetes type II in pregnant women.


Dosage:
The dosage and route of administration is defined individually in each case:
‎The drug is administered subcutaneously, IM or IV.
‎In case of monotherapy the drug is administered 3 times per day or up to 5 -6 times if necessary.
‎If the daily dose exceeds 0.6 IU/Kg, insulin H bio R is injected two or more times /day into different parts of the body.


Presentation:
Box containing vial of 10ml containing human recombinant insulin 40 or 100 IU/ ml


© 2004 Sedico Co. All rights reserved
Designed and Developed by EBM Co.